ANGLE plc

LSE AGL.L

ANGLE plc Operating Income for the year ending December 31, 2023: USD -27.68 M

ANGLE plc Operating Income is USD -27.68 M for the year ending December 31, 2023, a 5.37% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

ANGLE plc Operating Income for the year ending December 31, 2022 was USD -29.26 M, a -25.44% change year over year.
ANGLE plc Operating Income for the year ending December 31, 2021 was USD -23.32 M, a -24.38% change year over year.
ANGLE plc Operating Income for the year ending December 31, 2020 was USD -18.75 M, a -7.67% change year over year.
ANGLE plc Operating Income for the year ending December 31, 2019 was USD -17.41 M, a -22.61% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

LSE: AGL.L

ANGLE plc

CEO	Mr. Andrew David William Newland ACA, Meng
IPO Date	March 17, 2004
Location	United Kingdom
Headquarters	Surrey Research Park
Employees	150
Sector	Health Care
Industries Biotechnology Medical Instruments Pharmaceuticals

Description

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.

Key trends

Past 5 years